Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
about
IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cellsThe Origin and Activities of IgA1-Containing Immune Complexes in IgA NephropathyCurrent Understanding of the Role of Complement in IgA NephropathyEnzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathyHeavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schönlein purpura.Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor.Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodiesThe genetics and immunobiology of IgA nephropathy.Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease.IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease).Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathySpecificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge regionIgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cellsVariants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA NephropathyO-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis.Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.Galectin-8 in IgA nephritis: decreased binding of IgA by galectin-8 affinity chromatography and associated increased binding in non-IgA serum glycoproteins.IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic miceIgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.Biomarkers in IgA nephropathy: relationship to pathogenetic hits.Immune complex assays: diagnostic and clinical application.Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexesIgA nephropathy--human disease and animal model.In vivo activation of complement by IgA in a rat model.
P2860
Q24655890-FBC6A68A-6B9E-4146-ACDD-B63949B229C8Q26752555-163DED22-C311-49B7-A7FE-24CF3C11B0C8Q26852163-40A844A7-96D1-4339-AC84-67EC13E67D56Q28539595-0D956618-0CB5-4480-ABC8-28CC5F337A7FQ30311822-2CAD6C1E-2C4C-4B05-B1CA-F5681F76739CQ33579128-E83D8256-EEEC-4833-B8D3-6DC467CA0D17Q33654763-695069E5-8BDA-42B2-BAA0-11327A956834Q33660620-81CEF9FF-A48C-40F7-A012-1D60D854932BQ33853373-6B94029E-23D7-4D03-80D2-C41DF40AF6B6Q33872517-D41C53A7-AED5-446F-B702-C781A3C0A34DQ34009143-C3636835-1791-4F94-BA74-E0B6597D016EQ34070968-2C6A6ED4-2958-4BAC-AD0D-C6CCC5E9D35BQ34207864-396EC932-F215-4579-8EAD-501A88D81890Q34324220-EEEE4333-2523-4C0A-9A0E-01B35C3FE12DQ34655605-781B5896-0201-4F1A-B8AD-FD243DBCA12FQ35225422-B9459AEB-97F8-47BB-A9DD-63E4B1E193DBQ35468711-5C3633B3-6F26-4335-99F3-0F4F8811A576Q35550560-D5D778AF-EF02-4192-B8E8-D37A5DBFD65BQ35804190-E65EEED1-1111-45DC-9AEB-40E96734D40EQ35815206-B7C5B16C-2C4B-4394-B69F-CA36E29FF703Q35834840-2E922B2A-20E5-4AFD-91BC-A609BE2FA04DQ36303703-A32091E7-2408-4AE2-8018-BFCA87868A08Q36404662-3E90C8EB-4DC2-4877-8600-33A08045CE9BQ36456627-110A55FC-FA9A-4DDF-92A7-B97E108AB665Q37177864-1CD28184-1F02-4B94-B78B-A97BD9997D08Q38157013-F40DB694-D430-4FBB-82CF-8862DCC3E05EQ38694115-F345365D-D4E0-458C-A797-E2FF68C3DEEBQ41226342-96F11BCA-E8E5-4958-8647-C69433C00227Q41473241-3113CAE1-5682-4BEA-BDA5-009B62037137Q44723362-68C71DE9-6A94-43F2-A493-68EB49CAD127
P2860
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Circulating immune complexes a ...... mmunoglobulin A nephropathies.
@en
type
label
Circulating immune complexes a ...... mmunoglobulin A nephropathies.
@en
prefLabel
Circulating immune complexes a ...... mmunoglobulin A nephropathies.
@en
P2093
P2860
P356
P1476
Circulating immune complexes a ...... mmunoglobulin A nephropathies.
@en
P2093
B A Julian
C Czerkinsky
J E Collins
J Mestecky
R E Schrohenloher
W J Koopman
P2860
P304
P356
10.1172/JCI112522
P407
P577
1986-06-01T00:00:00Z